Daniel Newman Mendelson

CIK: 0001327897

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CSBR

CHAMPIONS ONCOLOGY, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

CSBR
CHAMPIONS ONCOLOGY, INC.
Nov 5, 2025
Award(A)
Option to purchase Common Stock
Direct
13.8K shares at avg. $6.80-
CSBR
CHAMPIONS ONCOLOGY, INC.
Nov 12, 2024
Award(A)
Option to purchase Common Stock
Direct
21.6K shares at avg. $4.64-

		Type	Shares	Price		Ownership
Nov 5, 2025	CSBR CHAMPIONS ONCOLOGY, INC.	Award(A) Option to purchase Common Stock	13,790	$6.80	-	Direct
Nov 12, 2024	CSBR CHAMPIONS ONCOLOGY, INC.	Award(A) Option to purchase Common Stock	21,590	$4.64	-	Direct

1-2 of 2 transactions

About Mendelson Daniel Newman

Mendelson Daniel Newman (SEC CIK 0001327897) files insider reports with the SEC as Director of CHAMPIONS ONCOLOGY, INC. (CSBR).

Signal8 holds 2 ownership filings by Mendelson Daniel Newman, all Form 4s, filed between Nov 18, 2024 and Nov 7, 2025. Those filings report 2 transactions, from Nov 12, 2024 to Nov 5, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Mendelson Daniel Newman's filings is in HACKENSACK, NJ.

Recent filings by Mendelson Daniel Newman

Nov 5, 2025: Grant or award of CSBR derivative securities (Form 4, code A).
Nov 12, 2024: Grant or award of CSBR derivative securities (Form 4, code A).

Other insiders filing for CHAMPIONS ONCOLOGY, INC. (CSBR)

How to read Form 4 transaction codes